May 7 (Reuters) - Alvotech SA ALVO.O:
POTENTIAL U.S. TARIFFS ON PHARMACEUTICALS EXPECTED TO HAVE MINIMAL IMPACT ON ALVOTECH'S PRODUCT REVENUES IN 2025
ALVOTECH MANUFACTURES ITS BIOSIMILARS IN ICELAND, A COUNTRY WHICH CURRENTLY FACES MINIMUM TARIFF OF 10% ON GOODS IMPORTED TO U.S
A 10% TARIFF ON PHARMACEUTICALS WOULD RAISE COST OF BIOSIMILARS FROM ALVOTECH IMPORTED TO U.S. FOR CUSTOMERS BY LESS THAN 1% OF ALVOTECH'S EXPECTED TOTAL PRODUCT REVENUES IN 2025
Source text: ID:nGNEKfYb3
Further company coverage: ALVO.O
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))